H. Waal-Manning

发表

Some norms and reliability data for the State--Trait Anxiety Inventory and the Zung Self-Rating Depression scale.

G. Spears, R. Knight, H. Waal-Manning, 1983, The British journal of clinical psychology.

Relationship of blood pressure to sodium excretion in a population survey.

G. Spears, H. Waal-Manning, P. Bolli, 1978, Clinical science and molecular medicine. Supplement.

Smoking habit and psychometric scores: a community study.

H. Waal-Manning, F. D. de Hamel, H. Waal‐Manning, 1978, The New Zealand medical journal.

Effect of equivalent antihypertensive doses of mefruside and cyclopenthiazide on serum electrolytes, uric acid and glucose tolerance in hypertensive patients

H. Waal-Manning, 1975, Clinical and experimental pharmacology & physiology.

The Role of Calcium Supplementation in the Treatment of Hypertension

D. Grobbee, H. Waal-Manning, 2012, Drugs.

The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine.

G. Spears, A. Goulding, H. Waal-Manning, 1978, The New Zealand medical journal.

The antihypertensive action of several beta-adrenoreceptor-blocking drugs.

H. Waal-Manning, 1976, The New Zealand medical journal.

Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.

H. Waal-Manning, F. O. Simpson, H. Waal‐Manning, 1969, Lancet.

Adverse effects from metoprolol are not generally associated with oxidation status.

H. Waal-Manning, D. Clark, A. Morgan, 1984, British journal of clinical pharmacology.

The Prevalence of Headache in a Small New Zealand Town

H. Waal-Manning, J. Paulin, F. Simpson, 1985, Headache.

The Spielberger Anger Expression Scale: some psychometric data.

R. Knight, H. Waal-Manning, J. Paulin, 1988, The British journal of clinical psychology.

Can β-Blockers be Used in Diabetic Patients?

H. Waal-Manning, H. Waal‐Manning, 1979, Drugs.

COMPARISON OF TIENILIC ACID WITH CYCLOPENTHIAZIDE IN HYPERURICÆMIC HYPERTENSIVE PATIENTS

H. Waal-Manning, P. Simpson, 1978, The Lancet.

Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.

H. Waal-Manning, P. Bolli, H. Waal‐Manning, 1980, British journal of clinical pharmacology.

Further surveys in Milton, 1978 and 1981: blood pressure, height, weight and 24-hour excretion of sodium and potassium.

G. Herbison, H. Waal-Manning, E. Nye, 1982, The New Zealand medical journal.

Letter: Paradoxical effect of pindolol.

H. Waal-Manning, F. O. Simpson, H. Waal‐Manning, 1975, British medical journal.

Can beta-blockers be used in diabetic patients?

H. Waal-Manning, 1979, Drugs.

Effects of arm position and support on blood-pressure readings.

H. Waal-Manning, J. Paulin, 1987, Journal of clinical hypertension.

Renal function in patients with essential hypertension receiving nadolol.

C. Hobson, H. Waal-Manning, H. Waal‐Manning, 1980, British medical journal.

Hypertension: Which Beta-Blocker?

H. Waal-Manning, H. Waal‐Manning, 1976, Drugs.

Effect of propranolol on the duration of the Achilles tendon reflex

H. Waal-Manning, Hendrika J. Waal-Manning, H. Waal‐Manning, 1969, Clinical pharmacology and therapeutics.

Review of long-term treatment with labetalol.

H. Waal-Manning, F. O. Simpson, 1982, British journal of clinical pharmacology.

TOTAL BAN ON TIENILIC ACID

H. Waal-Manning, F. Simpson, 1980, The Lancet.

Experience with beta-adrenoreceptor blockers in hypertension.

H. Waal-Manning, 1976, Drugs.

Alcohol consumption and blood pressure in a New Zealand community study.

H. Waal-Manning, F. O. Simpson, J. Paulin, 1985, The New Zealand medical journal.

Practolol treatment in asthmatics.

H. Waal-Manning, F. O. Simpson, H. Waal‐Manning, 1971, Lancet.

The relationship between blood pressure and personality in a large unselected adult sample.

G. Spears, H. Waal-Manning, J. Paulin, 1986, Journal of psychosomatic research.

Experience with a slow-release formulation of oxprenolol.

G. Spears, H. Waal-Manning, 1978, The New Zealand medical journal.

Atenolol and three nonselective β‐blockers in hypertension

H. Waal-Manning, H. Waal‐Manning, 1979 .

Problems with Practolol

H. Waal-Manning, H. Waal‐Manning, 2012, Drugs.

Hemodynamic Characteristics of the Early Phase of Primary Hypertension The Dutch Hypertension and Offspring Study

A. Hofman, D. Grobbee, H. Waal-Manning, 1993, Circulation.

Metabolic Effects ofβ-Adrenoreceptor Blockers

H. Waal-Manning, 1976, Drugs.

Atenolol and three nonselective beta-blockers in hypertension.

H. Waal-Manning, 1979, Clinical pharmacology and therapeutics.

An examination of the psychometric properties of the Crown-Crisp Experiential Index.

G. Spears, H. Waal-Manning, R. G. Knight, 1983 .

The Milton Survey. 2. Blood pressure and heart rate.

G. Spears, H. Waal-Manning, P. Bolli, 1978, The New Zealand medical journal.

Eight‐year survival study of treated hypertension at the Dunedin Hypertension Clinic 1953–1977

H. Waal-Manning, F. O. Simpson, J. Paulin, 1988, Journal of Hypertension - Supplement.

Metabolic effects of beta-adrenoreceptor blockers.

H. Waal-Manning, H. Waal‐Manning, 1976, Drugs.